If you take medicine for diabetes, blood pressure, cholesterol, or thyroid every day, your annual chemist bill is probably between ₹15,000 and ₹60,000. For most Indian families, that's a significant share of household income.
Here's what most people don't realise: 60-80% of that cost is brand premium, not medicine. The active molecule — what actually treats your condition — costs the same to manufacture regardless of which company packages it.
What exactly is a generic medicine?
A generic medicine contains the same active ingredient, same strength, same dosage form, and same route of administration as the originator branded drug. It works the same way in your body, treats the same condition, and is held to the same quality standards by the Central Drugs Standard Control Organization (CDSCO).
The differences are:
- Brand name — Glycomet, Glyciphage, Diamicron etc. are brand names. Metformin is the molecule.
- Marketing & sales force costs — Big pharma companies spend ₹500–1,000 crore yearly on doctor visits, samples, and sponsorships. That cost lives in the price.
- R&D recovery — Originator brands need to recoup the ₹2,000–5,000 crore they spent developing the molecule. Once patent expires (usually 20 years), generic makers can produce it without that markup.
Real price comparison: chronic care medicines
| Branded | Generic | Branded price | Generic price | Saving |
|---|---|---|---|---|
| Glycomet 500 | Metformin 500mg | ₹98 | ₹22 | 78% |
| Lipitor 10 | Atorvastatin 10mg | ₹245 | ₹35 | 86% |
| Telma 40 | Telmisartan 40mg | ₹185 | ₹38 | 79% |
| Eltroxin 50 | Levothyroxine 50mcg | ₹118 | ₹28 | 76% |
| Pan 40 | Pantoprazole 40mg | ₹165 | ₹32 | 81% |
For a 60-year-old patient on metformin + atorvastatin + telmisartan (a very common combination for diabetics with cholesterol and BP), switching to generics saves about ₹16,000 per year. Over 10 years, that's a small car.
"But are generics safe?"
This is the most common worry, and it deserves a serious answer.
In India, every generic medicine sold must:
- Be approved by the CDSCO with proven bioequivalence to the originator brand (the body absorbs it the same way)
- Be manufactured in a facility that meets WHO-GMP standards (Good Manufacturing Practices)
- Pass batch-level quality control on identity, purity, and potency
The same Indian companies that make generics are often the ones exporting branded versions of these molecules to USA, UK, and Europe. Cipla, Sun Pharma, Dr Reddy's, Lupin, Torrent, Mankind — these are the biggest generic manufacturers in the world.
That said, not all generics are equal. The key is sourcing.
How to switch safely
- Talk to your doctor first. Tell them you want to switch from branded to generic. Most will be supportive — most government doctors prescribe generics by default.
- Match the molecule + strength exactly. 500mg means 500mg. Don't substitute different strengths.
- Buy from a verified pharmacy that buys directly from WHO-GMP manufacturers. AsliMeds lists the manufacturer and batch number on every product.
- Track your numbers for the first 1-2 months. Take BP/sugar readings as usual. If anything changes, talk to your doctor.
The bottom line
Generic medicines are not "cheap alternatives" — they're the same medicine sold without the marketing markup. Switching could save your family ₹10,000–60,000 a year with zero compromise on health.